The Preventive Effect of Oxytocin to Cisplatin-Induced Neurotoxicity: An Experimental Rat Model

Table 1

The alterations in electromyographic recordings in all groups.

	Normal control	Cisplatin + saline	Cisplatin + 80 μg/kg oxytocin	Cisplatin + 160 μg/kg oxytocin
CMAP latency (ms)	2.44 ± 0.02	2.58 ± 0.02	2.53 ± 0.05	2.51 ± 0.03
CMAP amplitude (mV)	10.23 ± 0.3	6.3 ± 0.26	7.9 ± 0.32	8.6 ± 0.21^#

Results were presented as mean ± standard error of mean.
< 0.05 versus control group; ^# < 0.05 versus cisplatin + saline group.